<DOC>
	<DOCNO>NCT01090986</DOCNO>
	<brief_summary>Non invasive ventilation ( NIV ) usually present air leak may determine result treatment . The clinical usefulness analyze ( quantify ) leak adaptation period NIV evaluate prospective clinical study predictive data treatment effectiveness . Our hypothesis air leak correlate successful adaptation NIV . And air leak magnitude may predict early failure treatment . And also , know air leak change adaptation period NIV , know whether early detection air leak play role therapeutic outcome . Our objective evaluate clinical usefulness quantify air leak adaptation period NIV predictor effectiveness treatment . We also want evaluate correlation air leak clinical-functional patient ' profile , ventilatory parameter select evaluate air leak variability adaptation period NIV . Method : We determine air leak magnitude twenty patient adaptation NIV . We use VPAP III ventilator ( ResMed , Australia ) , commercial nasal mask ( Mirage Ultra Mirage ) VPAP III/ResLinkTM ( ResMed , North Ryde , Australia ) , device include monitoring system couple VPAP III ventilator . This device allow record air leak ventilation parameter . We perform four VPAP III/ResLinkTM recording patient ( last night hospital adaptation period , first night home , one two month later , initiation NIV treatment ) . We also perform complete pulmonary function test , quality-of-life questionnaire ( SF36 ) , tolerance NIV questionnaire patient onset NIV treatment two month later . We evaluate patient need change treatment end adaptation period NIV . We also analyze compare air leak magnitude four recording state .</brief_summary>
	<brief_title>Home Mechanical Ventilation Effectiveness Air Leaks</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Patients restrictive pulmonary disease ( slow evolution neuromuscular thorax cage disease , obesity nocturnal hypoventilation ) hypercapnic chronic respiratory failure standard criterion NIV . COPD patient need NIV another reason ( obesity , nocturnal hyperventilation nocturnal hypercapnic response oxygen ) . PaCO2 â‰¥ de 50 mmHg . Clinically stable ( least one month ) . Possibility fit nasal mask NIV treatment ( ultra mirage , mirage ) . Rapid evolution neuromuscular disease ( Amyotrophic Lateral Sclerosis ) . Serious comorbidity . Lack patient comprehension collaboration . Inability fit nasal mask NIV treatment ( ultra mirage , mirage ) . Treatment compliance &lt; 4h/d .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Restrictive pulmonary disease hypercapnic chronic respiratory failure .</keyword>
	<keyword>COPD patient need NIV hypercapnic chronic respiratory failure .</keyword>
</DOC>